Company Overview of Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc., a biotechnology company, engages in the discovery and development of disulfide rich peptides (DRP), various alternatives to antibodies, and new chemical entities against those targets and life threatening diseases. It applies its DRP technology platform to the discovery and preclinical development of injectable and orally stable IL-6 peptide antagonists; and to identify orally stable DRPs against gastrointestinal targets linked to disease, as well as for identifying specific targets from the ion channel, GPCR, and cytokine families. The company was founded in 2001 and is based in Palo Alto, California.
3941 East Bayshore Road
Palo Alto, CA 94303
Founded in 2001
Key Executives for Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Aduro BioTech, Inc.||United States|
|Latam Clinical Trials, Inc.||United States|
|Paloma Pharmaceuticals, Inc.||United States|
|TAXIS Pharmaceuticals, Inc.||United States|
|Prologue Research International, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Seattle, WA | Marina Sirras & AssociatesPosted: Apr 09
- Tarrytown, NY | BASFPosted: May 22
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
To contact Protagonist Therapeutics, Inc., please visit www.protagonist-inc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.